SUBSCRIBE
SUBSCRIBE
News   Business

Myriad Genetics, Inc. to Announce Fiscal 2012 Third Quarter Results on Tuesday, May 1, 2012

April 11, 2012 | 
1 min read
SALT LAKE CITY, April 10, 2012 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that it will issue financial results for the third fiscal quarter following the close of market on Tuesday, May 1, 2012.
Earnings
MORE ON THIS TOPIC
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Pfizer, Geron Downsize To Streamline Costs
December 12, 2025
 · 
95 min read
 · 
BioSpace Editorial Staff
Creative collage illustration of financial business. Two businessmen shaking hands for partners agreement. Conceptual illustration of success deal, corporate ethic, connection.
Weight loss
Zealand Bets up to $2.5B in Metabolic Pact With Chinese Biotech
December 11, 2025
 · 
2 min read
 · 
Tristan Manalac
Pictured: Pfizer's signage outside its office in Canada/iStock, JHVEPhoto
Layoffs
Pfizer’s Cost Cuts Claim 200+ Jobs in Switzerland: Report
December 11, 2025
 · 
2 min read
 · 
Tristan Manalac
Closeup of businessman give money to robot. Man pass banknote bribe to robotic assistant. AI and technology. Vector illustration.
Immunology and inflammation
Novartis Unites With Relation in $1.7B Inflammatory Skin Disease Pact
December 9, 2025
 · 
2 min read
 · 
Tristan Manalac